Trial Profile
Tirofiban versus abciximab and heparin versus bivalirudin in coronary artery disease patients undergoing PCI and stent placement and also receiving clopidogrel + aspirin
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 20 Jul 2011
Price :
$35
*
At a glance
- Drugs Abciximab (Primary) ; Bivalirudin (Primary) ; Heparin (Primary) ; Tirofiban (Primary)
- Indications Cardiovascular disorders; Coronary artery disease; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms TENACITY
- 20 Jul 2011 New trial record
- 01 Jun 2011 Results published in Catheterization and Cardiovascular Interventions.